(2012)
Human Th17 subsets.
Eur J Immunol 42(9),
2215-2220.
Prof. Dr. Christina Zielinski
Infection Immunology · Head +49 3641 532-1251 christina.zielinski@leibniz-hki.deCurriculum vitae
Main Research Areas
- Regulation of human T cells in physiological and pathological contexts
- Communication of human T cells with the tissue microenvironment
- Identification of pharmacological targets for T cell-based immunotherapies in chronic infections
Professional Career
| since 2021 | W3-Professorship (Chair of Department of Infection Immunology) at the Leibniz Institute for Natural Product Research and Infection Biology (Hans Knöll Institute), University of Jena |
| 2015 - 2020 | Professorship of the German Center for Infection Research (DZIF) at the Technical University of Munich |
| 2011 – 2015 | Clinical training in dermatology and allergology at the Charité–Universitätsmedizin Berlin (Department of Dermatology) and Clinical Scientist Track Program of the Berlin-Brandenburg School for Regenerative Therapies, Board certification 2015 |
| 2008 – 2011 | Postdoctoral training (DFG fellowship) at the Institute for Research in Biomedicine (IRB), Bellinzona, Switzerland (Supervisor: Federica Sallusto, PhD) |
| 2006 – 2008 | Clinical training in dermatology at the University of Tübingen (Head of department: Prof. Dr. med. M. Röcken) |
| 2007 | Doctor of Medicine (summa cum laude): “Intrinsic T cell defects in a mouse model of systemic lupus erythematosus“ |
| 2006 | Approbation (license to practice medicine) |
| 1999 – 2006 | Medical School at the University of Heidelberg (1 Semester Harvard Medical School, 1 Semester Duke Medical School), Scholar of the German National Academic Foundation (Studienstiftung des deutschen Volkes) |
Awards · Appointments · Scientific Activities
| 2023 | Elected Board member of the Germany Society for Immunology (DGFI) |
| 2023 | Member of the Editorial Board of the European Journal of Immunology |
| 2023 | Organizer of the German-Japanese Immunology Alliance |
| 2020 | Paul Langerhans Preis der Arbeitsgemeinschaft Dermatologische Forschung |
| 2019 | Ingrid zu-Solms Preis für Medizin |
| 2019 | Deutscher Neurodermitis Preis der Deutschen Dermatologischen Gesellschaft |
| 2015 | Vortragspreis auf dem International Congress on Autoinflammation, Dresden |
| 2014 | Forschungspreis der Deutschen Gesellschaft für Rheumatologie |
| 2014 | Silver Award der LEO Pharma Research Foundation für außerordentliche Beiträge zur Dermatologischen Forschung (European Society for Dermatological Research, ESDR) |
| 2014 | Wolfgang-Schulze Preis (Deutsche Rheuma-Liga) |
| 2013 | Oscar-Gans-Förderpreis (wichtigster Preis für dermatologische Forschung in Deutschland) |
| 2013 | Paul Janssen-Preis für Dermatologie und Immunologie der Deutschen Dermatologischen Gesellschaft |
| 2013 | Forschungspreis der Berliner Gesellschaft für Dermatologie |
| 2012 | Robert-Koch-Postdoktorandenpreis für Immunologie |
| 2012 | Nils-Ilja-Richter-Preis der Deutschen Gesellschaft für Autoimmun-Erkrankungen |
| 2012 | Celgene Award for Innovation in Inflammation and Immunology Research into Dermatological Diseases (bester europäischer Beitrag zur Dermatologie durch Nachwuchsforscher, European Society for Dermatological Research) |
| 2011 | Vortragspreis, European Academy and Clinical Immunology Conference, Istanbul |
| 2011 | gewähltes Mitglied der ‘ESDR Academy for Future Leaders in Dermatology’ |
| 2011 | Posterpreis, Schweizerische Gesellschaft für Allergologie und Immunologie, Lugano |
| 2010 | Posterpreis, Jahrestagung der Deutschen Gesellschaft für Immunologie, Leipzig |
| 2010 | Vortragspreis, World Immune Regulation Meeting, Davos |
Publications
(2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β.
Nature 484(7395),
514-518.
(2012)
Immunoregulation in cutaneous allergy: prevention and control.
Curr Opin Allergy Clin Immunol 12(5),
498-503.
(2011)
Dissecting the human immunologic memory for pathogens.
Immunol Rev 240(1),
40-51.
(2009)
Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients.
J Am Acad Dermatol 60(5),
863-868.
(2005)
Naive CD4+ T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyperproliferation due to intrinsic threshold defects in activation.
J Immunol 174(8),
5100-5109.
(2003)
Intrinsic T cell defects in systemic autoimmunity.
Ann N Y Acad Sci 987,
60-67.
